Q4 2014 Holdings
Filed 2015-02-02 | 15 holdings | $450.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Radius Health, Inc. | Common | 750469207 | $226.9K | 5,831,253 | 50.4% |
| EpiZyme, Inc.(EPZMEUR) | Common | 29428V104 | $45.5K | 2,413,819 | 10.1% |
| Aratana Therapeutics Inc.(PETXEUR) | Common | 03874P101 | $37.8K | 2,118,845 | 8.4% |
| Portola Pharmaceuticals, Inc. | Common | 737010108 | $34.6K | 1,220,672 | 7.7% |
| Nevro Corporation(NVROEUR) | Common | 64157F103 | $26.6K | 686,704 | 5.9% |
| Trivascular Technologies, Inc. | Common | 89685A102 | $22.3K | 1,776,692 | 5.0% |
| Celladon Corporation | Common | 15117E107 | $15.6K | 800,542 | 3.5% |
| PharmAthene, Inc. | Common | 71714G102 | $11.5K | 6,347,614 | 2.6% |
| Proteon Therapeutics, Inc. | Common | 74371L109 | $10.2K | 983,381 | 2.3% |
| Conatus Pharmaceuticals, Inc.(CNATEUR) | Common | 20600T108 | $8.3K | 1,192,080 | 1.9% |
| Verastem, Inc. | Common | 92337C104 | $7.5K | 816,683 | 1.7% |
| EnteroMedics, Inc. | Common | 29365M208 | $1.6K | 1,113,168 | 0.4% |
| Mast Therapeutics, Inc. | Common | 576314108 | $1.4K | 2,551,851 | 0.3% |
| Sangamo Biosciences, Inc.(SGMO) | Common | 800677106 | $342 | 22,487 | 0.1% |
| MacroGenics, Inc.(MGNX) | Common | 556099109 | $111 | 3,168 | 0.0% |